CanAssist Breast
IHC- and clinicopathology-based prognostic test estimating five-year distant recurrence risk in early-stage breast cancer.
- Developer
- OncoStem Diagnostics
- Intended use
- Risk Stratification
- Cancer scope
- Breast cancer
- Specimen
- Breast tumor tissue
- Molecular modality
- Protein
- Current version
- Current CanAssist Breast configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.